The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis

Relapsed Multiple Myeloma

(2011) S. Lonial   Hematology-American Society of Hematology Education Program

Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma

(2010) H. Ludwig et al.   HAEMATOLOGICA

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

(2009) H. M. Lokhorst et al.   BLOOD

Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial

(2009) Cyrille Hulin et al.   JOURNAL OF CLINICAL ONCOLOGY

Consolidation Therapy With Low-Dose Thalidomide and Prednisolone Prolongs the Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedure

(2009) Andrew Spencer et al.   JOURNAL OF CLINICAL ONCOLOGY

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

(2009) R Fonseca et al.   LEUKEMIA

Differential activities of thalidomide and isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells

(2009) Sarah A. Holstein et al.   LEUKEMIA RESEARCH

Treatment of Relapsed/Refractory Multiple Myeloma

(2009) Efstathios Kastritis et al.   SEMINARS IN HEMATOLOGY

Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities

(2008) B. Barlogie et al.   BLOOD

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial

(2008) A. Palumbo et al.   BLOOD

Eight-year median survival in multiple myeloma after total therapy 2: roles of thalidomide and consolidation chemotherapy in the context of total therapy 1

(2008) Maurizio Zangari et al.   BRITISH JOURNAL OF HAEMATOLOGY

A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma

(2008) Lisa K. Hicks et al.   CANCER TREATMENT REVIEWS

Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Thalidomide Plus Dexamethasone Compared With Dexamethasone As Initial Therapy for Newly Diagnosed Multiple Myeloma

(2008) S. Vincent Rajkumar et al.   JOURNAL OF CLINICAL ONCOLOGY